FAPI PET/CT improves staging of newly diagnosed breast cancer
Toronto, Ontario—A comparative analysis between FAPI and 18F-FDG PET/CT for the systemic staging of newly diagnosed breast cancer shows that FAPI PET/CT is more accurate in staging patients. Nearly 20 percent of patients were restaged by FAPI PET/CT, indicating the radiotracer’s efficacies and benefits for clinical